Company intelligence / Profile preview

Signal Relief

Provo, Utah, United Statessignalrelief.com ↗

Ownership: Private
Development stage: Commercial

Overview

Signal Relief markets a reusable, drug-free patch for musculoskeletal and chronic pain. The product uses patented technology with microscopic particles arranged in an array that acts as an antenna to detect and interrupt signals of pain before they reach the brain. Clinical trial data cited by the company claim over 90% of participants experienced reduced musculoskeletal pain using only the patch; average reported reduction was from a score of six to two on standard scales. Over 100,000 users have reportedly used their products.

Therapeutic areas: RheumatologyNeurology
Modalities: DeviceNon-pharmacological therapy
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Signal Relief.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Signal Relief.

Explore the full profile